Luc Girard

6PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 26, 2026
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.

Misty D Shields, Katherine G Minton, Hilal Ozakinci

|Mar 10, 2025
KSR2 Promotes Self-Renewal and Clonogenicity of Small Cell Lung Carcinoma.

Dianna H Huisman, Deepan Chatterjee, Robert A Svoboda

|Sep 19, 2024
ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers.

Ana Martin-Vega, Svetlana A Earnest, Alexander Augustyn

|Feb 22, 2024
Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.

Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim

|Jan 05, 2024
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.

Jin Ng, Ling Cai, Luc Girard

|Jul 10, 2023
Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of <i>MYC</i> paralogs.

Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim

Pageof 1